One such promoter is epithelial glycoprotein-2/EpCAM/17-1A (EGP2) promoter which selectively kills the EpCAM over expressing cells in many cancers by restricted expression of TK (thymidine kinase) followed by Ganciclovir (GCV) treatment [21], [22]. The gene discussed is TKT; the disease is cancer.